• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Proof of SARS-CoV-2 Genomes in Endomyocardial Biopsy with Latency After Acute Infection

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2020 Oct 9;S1201-9712(20)32215-3.
doi: 10.1016/j.ijid.2020.10.012. Online ahead of print.
Proof of SARS-CoV-2 Genomes in Endomyocardial Biopsy with Latency After Acute Infection


Heiko Pietsch[SUP] 1 [/SUP], Felicitas Escher[SUP] 1 [/SUP], Ganna Aleshcheva[SUP] 2 [/SUP], Christian Baumeier[SUP] 2 [/SUP], Lars Morawietz[SUP] 2 [/SUP], Albrecht Elsaesser[SUP] 3 [/SUP], Heinz-Peter Schultheiss[SUP] 4 [/SUP]



Affiliations

Abstract

Emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached pandemic level. Cardiovascular complications in COVID-19 have been reported frequently, however, evidence for causal relationship has not been established. We describe detection of SARS-CoV-2 viral genomes in a patient with heart failure symptoms investigating endomyocardial biopsy following a latent period of four weeks after onset of pulmonary symptoms. Viral infection was accompanied by myocardial inflammation indicating infection of the heart muscle.

Keywords: COVID-19; SARS-CoV-2; endomyocardial biopsy; viral myocarditis.
 
Back
Top Bottom